SG Americas Securities LLC Has $251,000 Position in Acadia Healthcare Company, Inc. $ACHC

SG Americas Securities LLC trimmed its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 96.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,733 shares of the company’s stock after selling 281,692 shares during the quarter. SG Americas Securities LLC’s holdings in Acadia Healthcare were worth $251,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Acadia Healthcare in the first quarter worth approximately $1,600,000. Goldman Sachs Group Inc. grew its position in Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after purchasing an additional 121,444 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after purchasing an additional 27,207 shares in the last quarter. American Century Companies Inc. raised its holdings in Acadia Healthcare by 531.5% during the second quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock worth $2,399,000 after buying an additional 88,995 shares during the last quarter. Finally, Prudential Financial Inc. lifted its stake in shares of Acadia Healthcare by 21.9% in the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after buying an additional 1,780 shares in the last quarter.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Cantor Fitzgerald boosted their target price on shares of Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. UBS Group lifted their price target on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday. TD Cowen boosted their price objective on Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, April 28th. Guggenheim increased their price objective on Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Acadia Healthcare currently has a consensus rating of “Hold” and a consensus target price of $27.46.

Acadia Healthcare Stock Down 0.4%

ACHC opened at $31.28 on Friday. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $32.82. The firm has a market capitalization of $2.88 billion, a P/E ratio of -2.56, a PEG ratio of 10.47 and a beta of 0.64. The company’s 50-day moving average is $26.06 and its 200 day moving average is $21.83. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. The business had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Research analysts expect that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.